Pharmacogenomics

Reliance Life Sciences also provides services to study the genetic variability that affects drug metabolism and response and hence in turn may affect the efficacy of the patient’s current and/or future treatments. In the realm of cardiovascular disease, optimal Warfarin dosage for individual patient, is offered via VKORC1 and CYP2C9 allelotyping. UGT1A1 genotype study is used to ascertain the toxicity profile for Irinotecan

Pharmacogenomic Services

• Warfarin Dose Determination test
• UGT1A1 Genotyping